PP

Pasit Phiasivongsa

Chief Technical Officer

Nurix Therapeutics

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Nurix Therapeutics
Industry
biotechnology
Employees
370.0
Seniority
C suite
Annual Revenue
54549000.0

Professional Summary

Pasit Phiasivongsa serves as Chief Technical Officer at Nurix Therapeutics. Nurix Therapeutics operates in the biotechnology sector with approximately 370.0 employees. The company is headquartered in San Francisco, California. Nurix Therapeutics generates annual revenue of 54549000.0.

Industry & Role Insights

  • MessageCEO tracks 381 executives in the biotechnology sector.
  • We have verified contacts for 2 executives at Nurix Therapeutics.
  • 13,743 executive contacts are available in California.
  • Our database includes 201,468 c suite-level executives.

Technologies

Salesforce Cloudflare DNS Amazon SES Outlook Greenhouse.io Google Cloud Hosting Mimecast Microsoft Office 365 CloudFlare Hosting Amazon AWS WP Engine Atlassian Cloud Adobe Marketing Cloud Mobile Friendly Google Font API WordPress.org Vimeo reCAPTCHA New Relic Typekit Google Maps (Non Paid Users) Nginx Google Maps Remote AI Android

Keywords

research life sciences biotechnology biotechnology: pharmaceutical preparations health care targeted protein modulation targeted protein degradation targeted protein elevation small molecule drugs e3 ligases deligase platform catalytic degradation dna-encoded libraries immuno-oncology hematology-oncology pipeline drugs cancer therapeutics antibody drug conjugates novel drugs e3 ligase inhibitors oncology therapies drug discovery clinical trials fda approvals biopharmaceutical protein levels modulation cancer treatment novel small molecules drug candidates therapeutic pipelines bivalent degraders target protein degradation drug resistance targeted therapies chemotherapy drug development cytokine blockers autoimmune diseases inflammatory conditions cancer immunotherapy biosimilars clinical-stage company proteasome targeting cancer biomarkers novel therapeutics drug efficacy therapeutic strategies biomarkers for cancer sitc ash annual meeting biotech partnerships gilead sciences sanofi pfizer small molecule therapies e3 ubiquitin ligases degrader-based medicines stat6 degrader bexobrutideg nx-5948 nx-2127 nx-1607 precision medicine innovative therapies clinical-stage strategic partnerships pharmaceutical collaborations unmet medical needs patient outcomes oncology inflammatory disorders drug modulation therapeutic innovation b2b partnerships healthcare providers cancer patients drug pipelines biotechnology firms academic research protein modulation patient-centric outcomes san francisco california health wellness & fitness hospital & health care

Related Executives

AS
Arthur Sands Chief Executive Officer at Nurix Therapeutics
CB
Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio
JL
Jason Loveridge CEO at 4SC AG
MM
Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant
JR
Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Pasit Phiasivongsa, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Pasit Phiasivongsa's Position in the MessageCEO Database

  • Pasit Phiasivongsa is 1 of 2 verified executive contacts we track at Nurix Therapeutics.
  • 365 verified executive contacts in biotechnology are in the MessageCEO database.
  • 12,901 verified executive contacts in California are in the database.
  • 3 verified contacts work at biotechnology companies in the 370.0 employee range (same size as Nurix Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

Frequently Asked Questions

How do I reach Pasit Phiasivongsa directly?

Pasit Phiasivongsa's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technical Officer at Nurix Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Pasit Phiasivongsa work for?

Pasit Phiasivongsa is Chief Technical Officer at Nurix Therapeutics, a company in the biotechnology sector with 370.0 employees. The company is based in San Francisco, California.

Can I pitch or sell to Pasit Phiasivongsa?

As Chief Technical Officer at Nurix Therapeutics, Pasit Phiasivongsa is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Pasit Phiasivongsa directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Pasit Phiasivongsa in?

Pasit Phiasivongsa works in the biotechnology industry as Chief Technical Officer at Nurix Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Pasit Phiasivongsa's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Pasit Phiasivongsa's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: July 26, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans